Key Personnel Update Keros Therapeutics recently appointed Jasbir S. Seehra as Chair of the Board and CEO, showcasing strong leadership, which can be leveraged for potential partnerships and collaborations.
Product Development Progress The development of Keros Therapeutics' products, including KER-050, KER-012, and KER-065, presents sales opportunities for providing innovative treatment solutions in rare hematologic and musculoskeletal disorders.
Expanding Treatment Portfolio Keros Therapeutics' focus on developing KER-065 for obesity treatment signifies a potential market expansion, offering sales prospects in a new therapeutic area.
Public Offering Impact With Keros Therapeutics going public, there is potential for increased visibility and investor interest, creating opportunities for sales growth and market recognition.
Clinical Trial Updates The ongoing Phase 2 trials of KER-050 and the upcoming Phase 2 trial for KER-012 demonstrate progress, providing avenues for engaging with healthcare providers and patients interested in novel therapies.
306
$10M$50M
70$10M$50M
204$10M$50M
168$10M$50M
2$10M
146$10M$50M
184$10M$50M
51$10M$50M
57$10M
11Keros Therapeutics uses 8 technology products and services including Squarespace, Backbone.js, Chart.js, and more. Explore Keros Therapeutics's tech stack below.
| Keros Therapeutics Email Formats | Percentage |
| FLast@kerostx.com | 79% |
| First@kerostx.com | 9% |
| First.Last@kerostx.com | 8% |
| Last.First@kerostx.com | 4% |
Biotechnology ResearchMassachusetts, United States51-200 Employees
Keros is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from rare hematologic and musculoskeletal disorders with high unmet medical need.
Company Overview
Media & News
Funding & FinancialsKeros Therapeutics has raised a total of $140M of funding over 5 rounds. Their latest funding round was raised on Jan 03, 2024 in the amount of $140M.
Keros Therapeutics's revenue is in the range of $10M$50M
Funding & FinancialsKeros Therapeutics has raised a total of $140M of funding over 5 rounds. Their latest funding round was raised on Jan 03, 2024 in the amount of $140M.
Keros Therapeutics's revenue is in the range of $10M$50M
1-888-653-2347 
support@leadiq.com